Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial

Tanaka, Kortaro, Ishikawa, Yuichi, Yokoyama, Mitsuhiro, Origasa, Hideki, Matsuzaki, Masunori, Saito, Yasushi, Matsuzawa, Yuji, Sasaki, Jun +9 more·2008·Stroke

Cited by (216)

Items 101–200 of 216

  1. Nutritional and metabolic supplementation for the injured brain: an update
    Hervé Quintard, Carole Ichaï · 2019 · Current Opinion in Critical Care
  2. Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
    Emily L. Flam, Joel T. Haas, Bart Staels · 2024 · Atherosclerosis
  3. Effect of flaxseed oil on biochemical parameters, hormonal indexes and stereological changes in ovariectomized rats
    Romina Tanideh, Shirin Delavari, Omid Farshad, Cambyz Irajie, Mohammad Javad Yavari Barhaghtalab, Farhad Koohpeyma, Omid Koohi‐Hosseinabadi, Akram Jamshidzadeh, Nader Tanideh, Aida Iraji · 2020 · Veterinary Medicine and Science
  4. Risks and Benefits of Fish Consumption For Childbearing Women
    Liana C. Del Gobbo, Josephine A. Archbold, Loren D. Vanderlinden, Chris S. Eckley, Miriam L. Diamond, Matthew Robson · 2010 · Canadian Journal of Dietetic Practice and Research
  5. Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: Implications for carotid interventions
    Hernan A. Bazán, Yan Lu, Deepu Thoppil, Tamara N. Fitzgerald, Song Hong, Alan Dardik · 2009 · Vascular Pharmacology
  6. Reduced Plasma Eicosapentaenoic Acid–Arachidonic Acid Ratio in Peripheral Artery Disease
    Masahiko Fujihara, Mitsuhiro Fukata, Keita Odashiro, Toru Maruyama, Koichi Akashi, Yoshiaki Yokoi · 2012 · Angiology
  7. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease
    Miki Kanoh, Kei Inai, Tokuko Shinohara, Hirofumi Tomimatsu, Toshio Nakanishi · 2017 · Heart and Vessels
  8. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients
    Shunsuke Watanabe, Akiomi Yoshihisa, Yuki Kanno, Mai Takiguchi, Tetsuro Yokokawa, Akihiko Sato, Shunsuke Miura, Takeshi Shimizu, Satoshi Abe, Takamasa Sato et al. · 2016 · Journal of Cardiac Failure
  9. Association of Serum Fatty Acids at Admission with the Age of Onset of Acute Ischemic Stroke
    Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno, Shigen Kasakura · 2020 · Nutrients
  10. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass
    Priscila Garla, Priscila Sala, Raquel Susana Torrinhas, Natasha Mendonça Machado, Danielle Cristina Fonseca, Mariane Marques da Silva, Graziela Rosa Ravacci, Giliane Belarmino, Robson Kiyoshi Ishida, Ismael Francisco Motta Siqueira Guarda et al. · 2018 · Clinical Nutrition
  11. Impact of polyunsaturated fatty acid consumption prior to ischemic stroke
    Masahiro Mishina, K. Kim, Shushi Kominami, Takayuki Mizunari, S Kobayashi, Y. Katayama · 2012 · Acta Neurologica Scandinavica
  12. Management of Cholesterol to Reduce the Burden of Stroke in Asia: Consensus Statement
    Graeme J. Hankey, Ka Sing Wong, Siwaporn Chankrachang, Christopher Chen, Denis S. Crimmins, Judith H. Frayne, Jong S. Kim, Yansheng Li, Chia‐Wei Liou, Julia S. Merican et al. · 2010 · International Journal of Stroke
  13. Royal C ollege of P hysicians I ntercollegiate S troke W orking P arty evidence‐based guidelines for the secondary prevention of stroke through nutritional or dietary modification
    C. Hookway, Filomena Gomes, Christine Elizabeth Weekes · 2014 · Journal of Human Nutrition and Dietetics
  14. Effects of Eicosapentaenoic Acid on Asymmetric Dimethylarginine in Patients in the Chronic Phase of Cerebral Infarction: A Preliminary Study
    Hiroshi Hagiwara, Yutaka Nishiyama, Yasuo Katayama · 2011 · Journal of Stroke and Cerebrovascular Diseases
  15. Long-Term Comparison of Ethyl Icosapentate vs. Omega-3-Acid Ethyl in Patients With Cardiovascular Disease and Hypertriglyceridemia (DEFAT Trial)
    Akira Sezai, Satoshi Unosawa, Makoto Taoka, Shunji Osaka, Kazuaki Obata, Sakie Kanno, Hisakuni Sekino, Masashi Tanaka · 2019 · Circulation Journal
  16. Efficacy of Polyunsaturated Fatty Acids (PUFAs) on Impulsive Behaviours and Aggressiveness in Psychiatric Disorders
    Silvio Bellino, Paola Bozzatello, Cristina Badino, Emanuela Mantelli, Paola Rocca · 2021 · International Journal of Molecular Sciences
  17. Association of Serum Fatty Acids at Admission with the Age of Onset of Intracerebral Hemorrhage
    Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno, Shigen Kasakura · 2020 · Nutrients
  18. The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
    Alexandra Tsankof, Κωνσταντίνος Τζιόμαλος · 2021 · Diseases
  19. Dyslipidemia in Chronic Kidney Disease
    Elani Streja, Dan A. Streja · 2022
  20. Low plasma eicosapentaenoic acid concentration as a possible risk factor for intracerebral hemorrhage
    Yoshimori Ikeya, Naoto Fukuyama, Hidezo Mori · 2015 · Nutrition Research
  21. Cerebrovascular Diseases
    Tamio Teramoto, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida et al. · 2013 · Journal of Atherosclerosis and Thrombosis
  22. Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia
    Sheila Anne Doggrell · 2019 · Expert Opinion on Pharmacotherapy
  23. Control of Fatty Acid Intake and the Role of Essential Fatty Acids in Cognitive Function and Neurological Disorders
    Kiran S. Panickar, Sam J. Bhathena · 2009 · Frontiers in neuroscience
  24. Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: Is there potential for adverse events? A systematic review of the literature
    Anthony M. Villani, Maria Crotty, Leslie G. Cleland, Michael J. James, Robert J. Fraser, Lynne Cobiac, Michelle Miller · 2013 · International Journal of Cardiology
  25. The Importance of Combined Antithrombotic Treatment for Capsular Warning Syndrome
    Hikaru Kamo, Nobukazu Miyamoto, Hana Otani, Naohide Kurita, Sho Nakajima, Yuji Ueno, Kazuo Yamashiro, Ryota Tanaka, Nobutaka Hattori · 2018 · Journal of Stroke and Cerebrovascular Diseases
  26. Omega-3 Polyunsaturated Fatty Acids Supplements and Cardiovascular Disease Outcome: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
    Qi Xue, Hechen Zhu, Ru Ya, Hao Huang · 2023 · Reviews in Cardiovascular Medicine
  27. A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial
    Terry A. Jacobson · 2012 · Expert Review of Cardiovascular Therapy
  28. Arachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational Studies
    Mai Sakai, Saki Kakutani, Hisanori Tokuda, Toshihide Suzuki, Masaru Kominami, Kahori Egawa, Kayo Saito, Tomohiro Rogi, Hiroshi Kawashima, Hiroshi Shibata et al. · 2014 · Cerebrovascular Diseases Extra
  29. The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial
    Takahito Moriyama, Saeko Kumon, Takahiro Kamiyama, Kazunori Karasawa, Keiko Uchida, Kosaku Nitta · 2017 · Internal Medicine
  30. Synergistic Effect of Eicosapentaenoic Acid on Antiproliferative Action of Anticancer Drugs in a Cancer Cell Line Model
    Ayako Ogo, Sachi Miyake, Hisako Kubota, Masaharu Higashida, Hideo Matsumoto, Fusako Teramoto, Toshihiro Hirai · 2017 · Annals of Nutrition and Metabolism
  31. What Should Medical Practitioners Know about the Role of Alternative Medicines in Cardiovascular Disease Management?
    Thomas F. Whayne · 2010 · Cardiovascular Therapeutics
  32. Serum Fatty Acids Are Associated with a Higher Risk of Ischemic Stroke
    Sebastian Razvan Andone, Lénárd Farczádi, Silvia Imre, Zoltán Bajkó, Anca Moțățăianu, Smaranda Maier, Laura Bărcuţean, Rodica Bălașa · 2023 · Nutrients
  33. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
    James J. DiNicolantonio, Pascal Meier, James Henry O’Keefe · 2013 · Europe PMC (PubMed Central)
  34. Japanese Guidelines for the Management of Stroke 2009 -Important revised points necessary for the neurologist-
    Yukito Shinohara · 2010 · Rinsho Shinkeigaku
  35. Marine-derived n-3 fatty acids therapy for stroke
    Celia Gabriela Alvarez Campano, Mary Joan MacLeod, Lorna S. Aucott, Frank Thiès · 2019 · Cochrane Database of Systematic Reviews
  36. Omega-3 Fatty Acids
    William Stephen Harris · 2010 · CRC Press eBooks
  37. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia
    Ichiro Tatsuno · 2014 · Expert Review of Cardiovascular Therapy
  38. Pretreatment with and ongoing use of omega-3 fatty acid ethyl esters reduce the slow-flow phenomenon and prevent in-stent restenosis in patients undergoing carotid artery stenting
    Ichiro Nakagawa, Hun Soo Park, Shohei Yokoyama, Takeshi Wada, Shuichi Yamada, Yasushi Motoyama, Kimihiko Kichikawa, Hiroyuki Nakase · 2017 · Journal of Vascular Surgery
  39. Serum fatty acids and ischemic stroke subtypes in middle- and late-onset acute stroke patients
    Takahisa Mori, Yuhei Tanno, Shigen Kasakura, Kazuhiro Yoshioka, Noriyoshi Nakai · 2018 · Clinical Nutrition Experimental
  40. Features of serum fatty acids in acute ischaemic stroke patients aged 50 years or older
    Takahisa Mori, Kazuhiro Yoshioka · 2020 · BMC Cardiovascular Disorders
  41. Chrysanthemum ethanol extract induced loss of Kupffer cells via the mitochondria-dependent apoptotic pathway
    Wanli Liang, Yanzhang Wen, Fang Huang, Qin Hu, Xiaojun Li, Wei Kevin Zhang, Xinzhou Yang · 2020 · Food & Function
  42. The effect of omega-3 polyunsaturated fatty acids on stroke treatment and prevention: a systematic review and meta-analysis
    Qian Xu, Lingling Du, Heng Gu, Meng Ji, Ling Zhan · 2022 · Nutrición Hospitalaria
  43. Dietary Reference Intakes for Japanese 2010: Fat
    Osamu Ezaki, Yoshihiro Miyake, Shinichi Sato, Hiroyasu Iso · 2012 · Journal of Nutritional Science and Vitaminology
  44. Optimal Dose of n-3 Polyunsaturated Fatty Acids for Cardiovascular Event Prevention
    Yuji Nishizaki, Hiroyuki Daida · 2020 · Circulation Reports
  45. A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States
    Sephy Philip, Sumita Chowdhury, John R Nelson, P. Benjamin Everett, Carolyn K. Hulme-Lowe, Jordana K. Schmier · 2016 · Journal of Medical Economics
  46. Fish oil and secondary prevention of cardiovascular disease
    Eric John Brunner, Hiroyasu Iso · 2008 · BMJ
  47. Chronic Subdural Hematoma in a Patient With Congenital Afibrinogenemia Successfully Treated With Fibrinogen Replacement -Case Report-
    Naoto Sakai, Soichi Akamine, Tsutomu Tokuyama, Kenji Sugiyama, Naohiro Kanayama, Hiroki Namba · 2011 · Neurologia medico-chirurgica
  48. Fish, n-3 Polyunsaturated Fatty Acids, and Cardiovascular Disease
    Claire T. McEvoy, Ian Stuart Young, Jayne V. Woodside · 2012 · Humana Press eBooks
  49. Pharmacokinetics and Safety Profile of Omega-3 Polyunsaturated Fatty Acids
    Juan Luis Tamargo, María Tamargo · 2016 · Springer eBooks
  50. Marine-derived n-3 fatty acids therapy for stroke
    Celia Gabriela Alvarez Campano, Mary Joan MacLeod, Lorna S. Aucott, Frank Thiès · 2022 · Cochrane Database of Systematic Reviews
  51. Omega‐3 and hemocompatibility‐related adverse events
    Teruhiko Imamura, Ann B. Nguyen, Daniel E. Rodgers, Gene H. Kim, J. Raikhelkar, Sara Kalantari, Nikhil Narang, Colleen Juricek, Takeyoshi Ota, Valluvan Jeevanandam et al. · 2019 · Journal of Cardiac Surgery
  52. Scientific Opinion on the tolerable upper intake level for supplemental docosahexaenoic acid
    Novel Foods and Food Allergens (NDA) EFSA Panel on Nutrition, Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline J. M. Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, Angeles M. Jos, Alexandre Maciuk, Inge Mangelsdorf et al. · 2026 · EFSA Journal
  53. Low dihomo-γ-linolenic acid is associated with susceptibility vessel sign in cardioembolism
    Takeo Sato, Kenichiro Sakai, Motohiro Okumura, Tomomichi Kitagawa, Hiroki Takatsu, Maki Tanabe, Teppei Komatsu, Kenichi Sakuta, Tadashi Umehara, Hidetomo Murakami et al. · 2022 · Thrombosis Research
  54. Explaining the Recent Fish Oil Trial “Failures”
    James J. DiNicolantonio Asfandyar K. Niazi · 2013 · Journal of Glycomics & Lipidomics
  55. Do omega-3 fatty acids cause prostate cancer?
    James J. DiNicolantonio, Mark Frederick McCarty, Carl J. Lavie, James Henry O’Keefe · 2013 · Europe PMC (PubMed Central)
  56. Eicosapentaenoic Acid as long‐term secondary prevention after ischemic stroke
    Taizen Nakase, Masahiro Sasaki, Akifumi Suzuki · 2015 · Clinical and Translational Medicine
  57. Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease
    Elani Streja, Dan A. Streja, Melissa Soohoo, Carola‐Ellen Kleine, Jui‐Ting Hsiung, Christina Park, Hamid Moradi · 2018 · Seminars in Nephrology
  58. The vital prognosis of elderly adults living in a group home in their mid-eighties
    Kikue Todoroki, Yoshimori Ikeya, Sayato Fukui, Chiharu Tanaka, Kaori Sekine, Ryoko Imazeki, Toru Shizuma, Naoto Fukuyama, Hidezo Mori · 2016 · The Journal of Physiological Sciences
  59. Effects of Ecklonia arborea or Silvetia compressa algae intake on serum lipids and hepatic fat accumulation in Wistar rats fed hyperlipidic diets
    Laura Acevedo-Pacheco, Ana Rocío Múzquiz de la Garza, Elena Palacios, Janet Alejandra Gutierrez-Uribe, Armando Trejo-Chávez, Lucía Elizabeth Cruz‐Suárez, Sergio Othón Serna-Saldivar · 2020 · Algal Research
  60. Japan EPA Lipid Intervention Study (JELIS). Randomized clinical trial involving primary and secondary prevention of cardiovascular events with EPA in hypercholesterolemia
    Mitsuhiro Yokoyama · 2009 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  61. The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
    Ayako Ogo, Sachi Miyake, Hisako Kubota, Masaharu Higashida, Hideo Matsumoto, Fusako Teramoto, Toshihiro Hirai, Tomio Ueno · 2021 · Anticancer Research
  62. Omega-3 fatty acids, cognitive impairment and Alzheimer's disease
    M.M.A. Phillips · 2010 · Reviews in Clinical Gerontology
  63. Dietary Intake and Intervention in Chronic Stroke: Review of the Evidence
    Monica C. Serra · 2017 · Journal of Neurology & Neurophysiology
  64. Fish Consumption and the Risk of Stroke
    Tilman E. Kuhn · 2014 · Current Nutrition Reports
  65. Effects of Oxidative Stress, Hyperglycemia, and Hypercholesterolemia on Membrane Structural Organization and the Interactions of Omega-3 Fatty Acids
    Richard Preston Mason, Robert Francis Jacob · 2017 · Springer series in biophysics
  66. Independent factors affecting hemorrhagic and ischemic stroke in patients aged 40–69 years: a cross-sectional study
    Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno, Shigen Kasakura · 2022 · BMC Cardiovascular Disorders
  67. Omega-3 polyunsaturated fatty acids and its use in Parkinson's disease
    Abril Ramírez-Higuera, Carolina Peña-Montes, Alejandra Barroso-Hernández, Óscar López‐Franco, Rosa María Oliart‐Ros · 2023 · Elsevier eBooks
  68. The Benefits of Marine Omega-3s for the Prevention and Treatment of Cardiovascular Disease.
    James J. DiNicolantonio, James Henry O’Keefe · 2019 · Europe PMC (PubMed Central)
  69. Intensive Medical Management to Prevent Large and Small Artery Atherothrombotic Stroke
    Meng Lee, Bruce I Ovbiagele, Jeffrey L. Saver · 2021 · JAMA
  70. Does Fish Oil Reduce the Risk of Cardiovascular Events and Death? Recent Level 1 Evidence Says Yes: PRO: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease.
    James J. DiNicolantonio, James Henry O’Keefe · 2021 · PubMed Central
  71. Association of blood eicosapentaenoic acid levels with intracerebral hemorrhage during the COVID-19 pandemic: preliminary experience from a single-center in Japan
    Kenichiro Hira, Yuji Ueno, Nobukazu Miyamoto, Sho Nakajima, Chikage Kijima, Nobutaka Hattori · 2022 · BMC Neurology
  72. Stroke prevention - other nutrients
    2010 · Arbor Clinical Nutrition Updates
  73. Reducing cardiovascular risk - are omega 3 fatty acids the solution?
    Julia Silldorff, Tomasz Fura, Marcin Dudek, Radosław Zaucha, Zuzanna Felińska, Oliwia Iszczuk, Stanisław Anczyk, Magdalena Gajkiewicz, M Zajac · 2024 · Quality in Sport
  74. Relationship between EPA or EPA/AA and arteriosclerosis in elderly patients over 80 years old
    Mari Nakabou, Tatsuya Kai, Tetsuya Maeshima, Ken Kanamasa · 2011 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  75. Risk Assessment of “Other Substances” –Eicosapentaenoic Acid, Docosapentaenoic Acid and Docosahexaenoic Acid
    Livar Frøyland, Margaretha A. Haugen, Kristin Holvik, Martinus Løvik, Tor Arne Strand, Grethe Seppola Tell, Arild Vaktskjold, Per Ole Iversen · 2018 · European Journal of Nutrition & Food Safety
  76. Features of Serum Fatty Acids at Acute Ischemic Stroke Onset in Statin-Treated Patients with Hypercholesterolemia
    Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno, Shigen Kasakura · 2020 · Nutrients
  77. Fatty Acid Treatment with Pure Omega-3 Eicosapentaenoic Acid Ethyl Ester for Patients with Cardiovascular Diseases: Differences between Branded (EPADEL®) and Generic Products
    Michihiro Suwa, Isao Morii, Masaya Kino · 2020 · Food and Nutrition Sciences
  78. Brain Poster Session: Neuroprotection
    2009 · Journal of Cerebral Blood Flow & Metabolism
  79. Factors related to dietary quality among older stroke high-risk population in Tianjin community, China: a multicenter study
    Yumeng Gu, Decheng Gao, Xiaoshuang Xia, Juanjuan Xue, Dongliang Wang, Zhiqiang Wei, Xiaolin Tian, Xin Li · 2023 · BMC Geriatrics
  80. Eicosapentaenoic Acid Level Predicts Long-Term Survival and Cardiovascular or Limb Event in Peripheral Arterial Disease
    Hisao Kumakura, Ryuichi Funada, Yae Matsuo, Toshiya Iwasaki, Kuniki Nakashima, Eitoshi Tsuboi, Shûichi Ichikawa · 2024 · Annals of Vascular Diseases
  81. Fish Oils (Omega-3 Fatty Acids, Docosahexaenoic Acid, Eicosapentaenoic Acid, Dietary Fish, and Fish Oils)
    Joseph E. Pizzorno, Cristiana I. Paul, Alexander G. Schauss · 2013 · Elsevier eBooks
  82. Fish Oils and Omega-3 Fatty Acids
    John Nowicki, Cristiana I. Paul, Alexander G. Schauss, Joseph E. Pizzorno · 2020 · Elsevier eBooks
  83. Omega-3 Fatty Acids in Intellectual Disability, Schizophrenia, Depression, Autism, and Attention-Deficit Hyperactivity Disorder
    Basant K. Puri, Dina Gazizova · 2014 · Elsevier eBooks
  84. An Investigation of Outcomes in Relation to Thiamin Status of Ambulatory Patients with Heart Failure
    Mavra Ahmed · 2012 · TSpace (University of Toronto)
  85. Dietary fat and the risk of having a stroke
    John C. Stanley · 2009 · Lipid Technology
  86. Anti-aging and diet
    Yoko Fujiwara · 2009 · Drug Delivery System
  87. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of
    Ichiro Tatsuno · 2014
  88. Importance and proper use of fatty acid levels in vascular events
    Yoshimori Ikeya, Naoto Fukuyama, Hidezo Mori · 2015 · Nutrition Research
  89. The Fatty Acids-Inflammation Relationship Across The Lifecycle
    Huifen Wang · 2011 · University of Minnesota Digital Conservancy (University of Minnesota)
  90. Novel brain protection therapy: EPA
    Masayuki Ueda · 2014 · Nosotchu
  91. 5. Management of Chronic Stroke for Advanced Aged Person in Aging Society
    Tatsushi Kamiya, Yasuo Katayama · 2014 · Nihon Naika Gakkai Zasshi
  92. Japanese Guidelines for the Management of Stroke 2009 -the Way to Utilize and Cardinal Points for Primary and Secondary Stroke Prevention for Internists-.
    Yukito Shinohara · 2011 · Nihon Naika Gakkai Zasshi
  93. 1. Risk Factor Control for Preventing Stroke
    Naohisa Hosomi, Masayasu Matsumoto · 2014 · Nihon Naika Gakkai Zasshi
  94. 3. Cerebrovascular Disease; 2) Prevention of Stroke Recurrence and Therapeutic Strategies for Residual Symptoms
    Hidekazu Tomimoto, Yuichiro Ii · 2013 · Nihon Naika Gakkai Zasshi
  95. 5. Clinical Strokology for Physicians
    Hitoshi Aizawa · 2016 · Nihon Naika Gakkai Zasshi
  96. Stabilization of carotid unstable plaque by lipid control
    Motoshi Sawada, Yuto Yasokawa, Daisuke Mizutani · 2017 · Nosotchu
  97. Pharmacological treatment for dyslipidemia
    Kazuhisa Tsukamoto · 2018 · Journal of the Japanese Coronary Association
  98. Drugs for Treatment of Dyslipidemia Available in the USA
    Elani Streja, Dan A. Streja · 2019 · Springer eBooks
  99. Omega-3 Fatty Acids and Their Health Potentials to Human Life
    Oluwatosin Abidemi Ogunkalu · 2019 · DergiPark (Istanbul University)
  100. Endovascular Stent Grafting for Recurrent Strokes Due to Fragile Innominate Artery Plaque: A Case Report
    Takaaki Ishikawa, Tomosato Yamazaki, Masataka Satô, Noriyuki Kato, Eiichi Ishikawa, Yuji Matsumaru, Akira Matsumura · 2021 · NMC Case Report Journal